(Q34406806)

2 August 2017

1 reference

title

Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

2 August 2017

0 references

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

Akira Sasaki

1

1 reference

2 August 2017

Hiroyuki Nitta

2

1 reference

2 August 2017

Koki Otsuka

3

1 reference

2 August 2017

Akira Umemura

4

1 reference

2 August 2017

Shigeaki Baba

5

1 reference

2 August 2017

Toru Obuchi

6

1 reference

2 August 2017

Go Wakabayashi

7

1 reference

2 August 2017

language of work or name

1 reference

27 October 2014

1 reference

Frontiers in Endocrinology

2 August 2017

1 reference

2 August 2017

5

1 reference

2 August 2017

164

1 reference

Role of bariatric surgery in diabetes

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

The role of gastrointestinal hormones in hepatic lipid metabolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Gastrointestinal hormones and bariatric surgery-induced weight loss

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Pathophysiology of NASH: perspectives for a targeted treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Bariatric surgery and cardiovascular outcomes: a systematic review.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Diabetes remission after bariatric surgery: is it just the incretins?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Effect of weight loss on nonalcoholic fatty liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

The biology of incretin hormones

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Molecular mediators of hepatic steatosis and liver injury

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Obesity as a medical problem

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4209858

Current concepts and management approaches in nonalcoholic fatty liver disease.

6 July 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Epidemiology of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Metabolic/bariatric surgery worldwide 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Influence of Sleeve Gastrectomy on NASH and Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Effects of changes in adipocyte hormones and visceral adipose tissue and the reduction of obesity-related comorbidities after laparoscopic sleeve gastrectomy in Japanese patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFENDO.2014.00164

Histological findings in the liver before and after gastric bypass

21 January 2018

1 reference

12 December 2020

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

Effect of bariatric surgery on liver fibrosis

1 reference

12 December 2020

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Regression of hepatic steatosis in morbidly obese persons after gastric bypass

1 reference

12 December 2020

Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)

1 reference

12 December 2020

When GLP-1 hits the liver: a novel approach for insulin resistance and NASH

1 reference

12 December 2020

Identifiers

DOI

10.3389/FENDO.2014.00164

1 reference

2 August 2017

1 reference

2 August 2017

1 reference